Imunon (IMNN) 10-Q2004 Q3 Quarterly report

Filed: 15 Nov 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: adding, addressed, advanced, aid, area, assist, building, clock, collaboration, compliance, Contract, contracting, critical, departure, directly, Director, Doxorubicin, field, fill, formation, Gannon, health, laden, lease, malfunction, midnight, monitoring, National, newly, November, procedure, professional, prompt, provision, quantify, question, recall, remote, retained, reversible, short, situation, size, temporary, upgrade, Warning, William

Removed: Additionally, Augustine, authorized, Cheung, computation, incorporation, instruction, million, representing, restrictive, security, submission, vote

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

IMNN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 11

CELSION CORPORATION

COMPUTATION OF EARNINGS PER SHARE

CELSION CORPORATION

COMPUTATION OF EARNINGS PER SHARE


	Three Months Ended September 30,						Nine Months Ended September 30,
	2004			2003			2004			2003
Net loss attributable to common stockholders	$	(3,310,583	)	$	(3,731,586	)	$	(10,847,849	)	$	(11,470,168	)

Net (loss) income per common share*	$	(0.02	)	$	(0.03	)	$	(0.07	)	$	(0.10	)

Weighted average shares outstanding		160,639,842			136,135,077			158,062,867			119,818,566

*	Common stock equivalents have been excluded from the calculation of net loss per share as their inclusion would be anti-dilutive.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.